Particle.news

Download on the App Store

Umbilical Cord Blood Study Links Epigenetic Markers to Childhood Metabolic Risks

New findings presented at DDW 2025 reveal DNA methylation changes that could predict future metabolic health, with larger NIH-backed studies underway for validation.

Image
Image

Overview

  • Duke University researchers identified epigenetic markers in umbilical cord blood that correlate with metabolic health risks in children aged 7–12.
  • Key findings include altered methylation in genes like TNS3, GNAS, and CSMD1, linked to liver fat, blood pressure, and waist-to-hip ratio abnormalities.
  • The study highlights the influence of prenatal environments, such as maternal nutrition, on establishing these epigenetic markers during fetal development.
  • Presented at Digestive Disease Week 2025, the research underscores the potential for early interventions to mitigate long-term health risks.
  • Larger, NIH-funded studies are now underway to validate these findings and facilitate the development of clinical screening tools for at-risk newborns.